Last update: 12/03/21
Covid-19 and Inflammation
Executive Board
Missions and actions
GREMI PhD Thesis Prize
Mediators of Inflammation
Laboratories about Inflammation
Meetings on Inflammation
Contact and Feedback
Websites on Inflammation
Scientific Journals on Inflammation
Upcoming GREMI Meeting (TBA)
Sceau d'accréditation HONcode
Webmasters X. Norel (Email)
We comply with the HONcode standard for trustworthy health information.
© 2020-2023 GREMI, copyrights

Covid-19 and Inflammation

Scientific publications from GREMI members

Inflammation / Immunity

Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19. de Oliveira Formiga et al. Br J Pharmacol. 2023 Jun;180(11):1460-1481.

Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions. Soria et al. Allergy. 2023 Aug;78(8):2320-2323.

Immediate hypersensitivity to COVID-19 vaccines: Focus on biological diagnosis.
Nicaise-Roland et al. Front Allergy. 2022 Sep 30;3:1007602. doi: 10.3389/falgy.2022.1007602. eCollection 2022. PMID: 36249342 Free PMC article. Review.

Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19.
Peyneau et al. Sci Rep. 2022 Jan 12;12(1):638.

Differential activation of human neutrophils by SARS-CoV-2 variants of concern.
Lebourgeois et al. Front Immunol. 2022 Oct 27;13:1010140.

Circulating IL-6 but not neutrophil extracellular traps levels can predict anakinra effectiveness in patients with severe COVID-19.
Granger et al. J Leukoc Biol. 2022 Dec;112(6):1365-1367.

Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Flament et al., Nat Immunol. 2021 Mar;22(3):322-335.



Tackling osteoarthritis during COVID-19 pandemic.
Castro da Rocha et al., Ann Rheum Dis. 2021 Feb;80(2):151-153.

Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
COVID-19 Global Rheumatology Alliance. Putman et al., Arthritis Rheumatol. 2021 Jan;73(1):36-47.

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
Sattui et al., Expert Rev Clin Immunol. 2020 Jul;16(7):659-666.

Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.
COVID-19 Global Rheumatology Alliance. Graef et al., Ann Rheum Dis. 2020 Jun;79(6):734-736.

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.
im et al., Ann Intern Med. 2020 Jun 16;172(12):819-821.

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020. Richez et al., Joint Bone Spine. 2020 Oct;87(5):431-437.  

Kidney diseases

Scientific videos

On September 13th, 2021, the FHU SEPSIS organized a symposium "SEPSIS, the true visage of COVID-19: Better understand and better care"- World Sepsis Day
The GREMI particpated to this symposium : Immunology of sepsis and Covid-19: new players in Covid-19? (Sylvie Chollet-Martin)

Other scientific publications

Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group, N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
Arunachalam et al., Science. 2020 Sep 4;369(6508):1210-1220.

Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
Ryabkova et al., Clin Immunol. 2021 Feb;223:108652.

Animal models

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Maisonnasse et al., Nature. 2020 Sep;585(7826):584-587.